The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ARTICLENo Access

THE THERAPEUTIC SIGNIFICANCE OF FEAR IN THE METRAZOL TREATMENT OF SCHIZOPHRENIA

Published Online:https://doi.org/10.1176/ajp.95.6.1349

A method is described in which a physiological state, similar to if not identical with "fear" is induced. It has been employed in a series of 20 cases to investigate and compare the relative therapeutic significance of "fear" with the usual convulsant procedure in the metrazol treatment of schizophrenia. The method consists essentially of the slow intravenous injection of minimal amounts of metrazol. The "fear" states induced in this manner have a duration of a few minutes to several hours. The incidence of convulsive seizures can in this manner be fairly well controlled. In a group of 20 schizophrenic patients in whom this procedure was carried out on 10 successive days the therapeutic outcome after 1 month was compared with the same group treated with 10 daily convulsive seizures. The "fear of treatment" characterizing some patients was also studied in both procedures. It was shown that the procedure with "induced fear" was of less therapeutic value than that characterized by convulsions. Furthermore, the "fear of treatment" which has been differentiated from "induced fear" was again shown to be of little or no therapeutic significance.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.